Fosaprepitant dimeglumine equivaleng to fosaprepitant

Sold as Fosaprepitant cipla

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Loading Wikipedia summary

Registration

Applicants: 1
Registrations: 1

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Cipla Medpro (Pty) Ltd	Fosaprepitant cipla	150 mg	550452	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Fosaprepitant cipla EACH VIAL CONTAINS FOSAPREPITANT DIMEGLUMINE EQUIVALENG TO FOSAPREPITANT 150,0 mg	150 mgLyophilised powder for solution for infusion	55045255/5.7.2/0452Approved 7 February 2023	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsFosaprepitant cipla, Cipla Medpro (Pty) Ltd Patient information leaflet (PIL)For patients and carersFosaprepitant cipla, Cipla Medpro (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background